levofloxacin has been researched along with Inflammation in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 4 (26.67) | 2.80 |
| Authors | Studies |
|---|---|
| Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J | 1 |
| Akdis, CA; Claesson, MJ; Gehweiler, D; Heider, A; Hernandez, CJ; Magrath, W; Moriarty, TF; O'Mahony, L; Pugliese, B; Richards, RG; Stocker, N; Thompson, K; Wallimann, A; Westermann, P; Zeiter, S | 1 |
| Alvarado-Jáquez, MF; Bernal-Alferes, BJ; Burgos-Vargas, R; Chaparro-Barrera, E; Cuevas-Martínez, R; Espino-Solís, GP; González-Chávez, SA; López-Loeza, SM; Marín-Terrazas, C; Orrantia-Borunda, E; Pacheco-Tena, C; Romero-López, JP; Salas-Leiva, DE; Salas-Leiva, JS; Sausameda-García, J; Torres-Quintana, M | 1 |
| Deng, L; Ding, Z; Li, K; Wang, J; Zhang, Q; Zhang, Y; Zhao, C | 1 |
| Ho, SW; Lan, C; Sung, WW | 1 |
| Li, R; Li, XY; Song, XH; Wang, CL; Wang, R; Yang, YL; Zhang, TB; Zhang, WX | 1 |
| Gao, F; Liu, LM; Song, JT; Zhang, H | 1 |
| Franceschini, D; Frigo, AC; Giusti, P; Lo, R; Lunardi, V; Moro, S; Pagetta, A; Stifani, S; Zusso, M | 1 |
| Ahmadiyan, N; Mohammadzadeh, R | 1 |
| Nakajima, A; Oda, S; Sato, H; Yokoi, T | 1 |
| Blomme, EA; Ditewig, AC; Ganey, PE; Liguori, MJ; Roth, RA; Shaw, PJ; Waring, JF | 1 |
| Farney, AC; Mendley, SR; Mian, AN | 1 |
| Baltch, AL; Bopp, LH; Michelsen, PB; Ritz, WJ; Smith, RP; Um, S; Yan, SB | 1 |
| Ganey, PE; Hopfensperger, MJ; Roth, RA; Shaw, PJ | 1 |
| Andrews, JM; Child, J; Chow, AT; Mortiboy, D; Wise, R | 1 |
1 review(s) available for levofloxacin and Inflammation
| Article | Year |
|---|---|
Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway.
Topics: Animals; Anti-Inflammatory Agents; Ciprofloxacin; Humans; Inflammation; Levofloxacin; Mice; Microglia; NF-kappa B; Rats; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptor 4 | 2019 |
1 trial(s) available for levofloxacin and Inflammation
| Article | Year |
|---|---|
Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid.
Topics: Adolescent; Adult; Anti-Infective Agents; Cantharidin; Cross-Over Studies; Drug Administration Schedule; Exudates and Transudates; Half-Life; Humans; Inflammation; Levofloxacin; Male; Middle Aged; Ofloxacin | 1995 |
13 other study(ies) available for levofloxacin and Inflammation
| Article | Year |
|---|---|
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature | 2010 |
Butyrate Inhibits Osteoclast Activity
Topics: Animals; Anti-Bacterial Agents; Butyrates; Cell Differentiation; Cells, Cultured; Cytokines; Fatty Acids, Volatile; Fracture Healing; Gastrointestinal Microbiome; Humans; Inflammation; Inflammation Mediators; Levofloxacin; Male; Mice; Mice, Inbred C57BL; Osteoclasts; Osteotomy; Rifampin | 2021 |
Levofloxacin induces differential effects in the transcriptome between the gut, peripheral and axial joints in the Spondyloarthritis DBA/1 mice: Improvement of intestinal dysbiosis and the overall inflammatory process.
Topics: Animals; Dysbiosis; Inflammation; Levofloxacin; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; RNA, Ribosomal, 16S; Spondylarthritis; Transcriptome; Tumor Necrosis Factor-alpha | 2023 |
Comparative Study on the Efficacy of Two Perioperative Chemotherapy Regimens for Lumbar Brucellosis.
Topics: Brucellosis; Ceftriaxone; Doxycycline; Humans; Inflammation; Levofloxacin; Low Back Pain; Lumbar Vertebrae; Retrospective Studies; Rifampin; Spondylitis; Treatment Outcome | 2023 |
Man With Fever and Groin Mass.
Topics: Anti-Bacterial Agents; Diagnosis, Differential; Fever; Genital Diseases, Male; Groin; Humans; Inflammation; Levofloxacin; Male; Middle Aged; Point-of-Care Testing; Ultrasonography; Vas Deferens | 2021 |
[Transurethral seminal vesiculoscopy for the treatment of vesiculitis with hemospermia:A report of 64 cases].
Topics: Body Fluids; Calculi; Chlamydia trachomatis; Drainage; Ejaculatory Ducts; Genital Diseases, Male; Hemospermia; Humans; Inflammation; Lasers, Solid-State; Levofloxacin; Male; Operative Time; Postoperative Period; Prostate; Seminal Vesicles; Urethra | 2016 |
Therapeutic Effect of the Quinolone Levofloxacin on Inflammatory Fibroblast-like Synoviocytes.
Topics: Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Fibroblasts; Inflammation; Levofloxacin; Matrix Metalloproteinase 1; Matrix Metalloproteinase 3; Rabbits; Synoviocytes; Tissue Inhibitor of Metalloproteinase-1; Topoisomerase II Inhibitors | 2019 |
Novel agent for Helicobacter pylori infection management.
Topics: Animals; Anti-Bacterial Agents; Escherichia coli; Female; Galactosylceramides; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Intestines; Levofloxacin; Lymphocyte Activation; Male; Natural Killer T-Cells; Ofloxacin; Sphingomonas; Stomach | 2013 |
Fluoroquinolones and propionic acid derivatives induce inflammatory responses in vitro.
Topics: Allopurinol; Cell Line; Fluoroquinolones; Gene Expression Regulation; Humans; Inflammation; Levofloxacin; MAP Kinase Signaling System; Models, Biological; NF-kappa B; Phenylpropionates; Propionates; Protein Kinase Inhibitors; RNA, Messenger; Time Factors | 2018 |
Coexposure of mice to trovafloxacin and lipopolysaccharide, a model of idiosyncratic hepatotoxicity, results in a unique gene expression profile and interferon gamma-dependent liver injury.
Topics: Analysis of Variance; Animals; Chemical and Drug Induced Liver Injury; Female; Fluoroquinolones; Gene Expression; Hepatocytes; Inflammation; Interferon-gamma; Interleukin-18; Janus Kinases; Levofloxacin; Lipopolysaccharides; Liver; Liver Diseases; Male; Mice; Mice, Inbred BALB C; Naphthyridines; Necrosis; Ofloxacin; Oligonucleotide Array Sequence Analysis; STAT Transcription Factors; Transcriptional Activation | 2009 |
Mycoplasma hominis septic arthritis in a pediatric renal transplant recipient: case report and review of the literature.
Topics: Adolescent; Arthritis, Infectious; Doxycycline; Edema; Female; Graft Survival; Hip; Humans; Immunocompromised Host; Immunosuppressive Agents; Inflammation; Kidney Transplantation; Levofloxacin; Magnetic Resonance Imaging; Mycophenolic Acid; Mycoplasma hominis; Ofloxacin; Pelvis; Prednisone; Radiography; Tacrolimus; Treatment Outcome | 2005 |
Effect of recombinant human activated protein C on the bactericidal activity of human monocytes and modulation of pro-inflammatory cytokines in the presence of antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Blood Bactericidal Activity; Cytokines; Escherichia coli; Humans; In Vitro Techniques; Inflammation; Interleukin-1beta; Interleukin-8; Kinetics; Levofloxacin; Monocytes; Ofloxacin; Protein C; Recombinant Proteins; Tumor Necrosis Factor-alpha | 2007 |
Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha.
Topics: Alanine Transaminase; Animals; Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Etanercept; Fluoroquinolones; Immunoglobulin G; Inflammation; Levofloxacin; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred C57BL; Naphthyridines; Ofloxacin; Pentoxifylline; Receptors, Tumor Necrosis Factor; Time Factors; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2007 |